Loading...
Check-Cap Ltd. Ordinary Share
MBAI•NASDAQ
Healthcare
Medical - Diagnostics & Research
$1.60
$-0.14(-7.76%)
U.S. Market is Open • 12:41Check-Cap Ltd. Ordinary Share (MBAI) AI-Powered Stock Analysis
See how Check-Cap Ltd. Ordinary Share scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerCheck-Cap Ltd. Ordinary Share (MBAI) Stock Overall Grade
Check-Cap Ltd. Ordinary Share’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Check-Cap Ltd. Ordinary Share's overall stock rating.
Forecast
B+Score
72/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
50/100Key Ratios
C+Score
55/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
C+Score
50/100Check-Cap Ltd. Ordinary Share (MBAI) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 72/100 (B+), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Check-Cap Ltd. Ordinary Share stock grade, including financials, comparisons, and forecasts.